CS logo
small CS logo
Stadtspital Triemli; Augenklinik

Zurich, Switzerland
Medical clinic in Zürich
Birmensdorferstrasse 497, 8063 Zürich

About Stadtspital Triemli; Augenklinik


"Unsere Augenklinik bietet Patientinnen und Patienten mit komplexen Augenerkrankungen durch ihre Spezialsprechstunden Kompetenz in Diagnostik, medikamentöser und chirurgischer Therapie. Mit einem breiten interdisziplinären Netzwerk bieten wir individualisierte Möglichkeiten von Abklärung und Behandlung im ambulanten und stationären Bereich. Ein Team mit erfahrenen Spezialisten betreut folgende Schwerpunkte: Makulaerkrankungen, Diabetes, Uveitis, Netzhautablösung, Grauer Star (Cataract), Grüner Star (Glaukom), Lid-/plastische Chirurgie, Strabologie, Neuroophthalmologie, Kinderaugenheilkunde, Tumore (Onkologie)."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Stadtspital Triemli; Augenklinik


During the past decade, Stadtspital Triemli; Augenklinik conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Stadtspital Triemli; Augenklinik


According to Clinical.Site data, the most researched conditions in "Stadtspital Triemli; Augenklinik" are "Geographic Atrophy" (2 trials), "Neovascular Age-related Macular Degeneration (nAMD)" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "Stadtspital Triemli; Augenklinik" in a lesser frequency.

Clinical Trials Intervention Types at Stadtspital Triemli; Augenklinik


Most popular intervention types in "Stadtspital Triemli; Augenklinik" are "Drug" (4 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Lampalizumab" (2 trials), "Aflibercept" (1 trials), "Faricimab" (1 trials), "Port Delivery System with Ranibizumab" (1 trials) and "Ranibizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Stadtspital Triemli; Augenklinik


The vast majority of trials in "Stadtspital Triemli; Augenklinik" are 4 trials for "All" genders.

Clinical Trials Status at Stadtspital Triemli; Augenklinik


Currently, there are NaN active trials in "Stadtspital Triemli; Augenklinik". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Stadtspital Triemli; Augenklinik, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Stadtspital Triemli; Augenklinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".